# Management of Metastatic Breast Cancer in Frail Patients

> **NCT00005614** · PHASE2 · WITHDRAWN · sponsor: **H. Lee Moffitt Cancer Center and Research Institute**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00005614
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 1999-08
- **Primary completion:** 2000-06
- **Final completion:** 2000-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no accrual
- **Last updated:** 2012-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005614, "Management of Metastatic Breast Cancer in Frail Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00005614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*